前LA AG Charles C. Foti在第二阶段b审判失败和证券诉讼之后,开始对Akero治疗学进行调查。 Former LA AG Charles C. Foti launches investigation into Akero Therapeutics following Phase 2b trial failure and securities lawsuit.

前路易斯安那州总检察长Charles C. Foti Jr.通过其律师事务所Kahn Swick & Foti, LLC对Akero治疗公司(纳斯达克公司:AKRO)展开了调查。 Former Louisiana Attorney General Charles C. Foti, Jr. has launched an investigation through his law firm, Kahn Swick & Foti, LLC, into Akero Therapeutics, Inc. (NasdaqGS: AKRO). 这是继该公司第2阶段b SYMMETRY试验失败和正在审理的证券集团诉讼,指控未披露的材料信息之后发生的。 This follows the company's Phase 2b SYMMETRY trial failure and an ongoing securities class action lawsuit alleging undisclosed material information. 肯德基金融公司正在评估Akero高管可能违反信托义务的情况. KSF is assessing potential breaches of fiduciary duties by Akero's executives. 鼓励长期股东与KSF联系,寻求援助。 Long-term shareholders are encouraged to contact KSF for assistance.